antineoplastic-agents

Documents about antineoplastic-agents

• Evaluation of Reporting of Cardio-vascular Adverse Events With Antineoplastic and Immunomodulating Agents (EROCA)#1466018ClinicalTrials.gov
• Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients#804125ClinicalTrials.gov
• Adherence to oral antineoplastic agents, an overview and meta-analysis.#220856NCBI PubMed Central
• A Phase 1 Dose Escalation and Expansion Study of AK117#1280892ClinicalTrials.gov
• Educational Intervention on Oral Anticancer Agents for Community Pharmacists#967998ClinicalTrials.gov
• Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)#866883ClinicalTrials.gov
• Management of Malnutrition in Oncogeriatrics#881194ClinicalTrials.gov
• In Vitro Antineoplastic Effects of <i>Zataria multiflora</i>: A Systematic Review of Mechanisms, Selectivity, and Synergy#478571Europe PMC
• Impact of a Coordinated Regional Organization to Secure Patient's Care Treated by Oral Antineoplastic Agents#1321641ClinicalTrials.gov
• Preoperative Chemoradiation Followed by Chemotherapy for Locally Advanced Rectal Cancer#981509ClinicalTrials.gov
• Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic review.#151538PubMed
• A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid Tumors#852366ClinicalTrials.gov
• Bioequivalence Study of Anastrozole 1 mg Tablet#867019ClinicalTrials.gov
• Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)#1128051ClinicalTrials.gov
• A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma#1101677ClinicalTrials.gov
• Study of ADH-1 Given Intravenously to Patients With Solid Tumors#1444651ClinicalTrials.gov
• Natural Killer Cell (CYNK-001) Infusions in Adults with AML#898774ClinicalTrials.gov
• A Study of TPD3310 in Patients With Advanced Malignant Tumors#848252ClinicalTrials.gov
• Síntesis de un derivado de quinolina-5,8-diona y su potencial uso antineoplásico#1055157Repositorio Universidad del Desarrollo
• A Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors#1228494ClinicalTrials.gov
• A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors#1246922ClinicalTrials.gov
• Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)#813365ClinicalTrials.gov
• Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004)#1438309ClinicalTrials.gov
• Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma#887936ClinicalTrials.gov
• Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma#1422261Dipòsit Digital de la Universitat de Barcelona
• Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent#1281173ClinicalTrials.gov
• A Retrospective Study in Patients With Liver Injury After the Use of Novel Antineoplastic Agents#888233ClinicalTrials.gov
• Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer#889515ClinicalTrials.gov
• Pharmacovigilance Assessment of Reporting of Cardiovascular Adverse Events With Antineoplastic Agents (PARCA)#1451793ClinicalTrials.gov
• A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection#881747ClinicalTrials.gov
• A patent perspective of RSK inhibitors to treat cancer (2020-present).#631504PubMed
• ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors#859862ClinicalTrials.gov
• FLX475 in Combination With Ipilimumab in Advanced Melanoma#1230375ClinicalTrials.gov
• Vaccine Immune Recovery After Leukemia#1377232ClinicalTrials.gov
• Effects of Topical Sesame Oil in the Prevention of Peripheral Venous Catheter Phlebitis: Clinical Trial.#870127ClinicalTrials.gov
• A Research on the Hospital Pollution Control and Hygine Intervention of Chemotherapy Drugs Exposure#1395237ClinicalTrials.gov
• Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype.#1429218Apollo
• Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen#1088998ClinicalTrials.gov
• Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis C#1137887ClinicalTrials.gov
• Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma#848853ClinicalTrials.gov
• Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer#887844ClinicalTrials.gov
• Shared Health Information System for Febrile Neutropenia#1150329ClinicalTrials.gov
• A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days#1170540ClinicalTrials.gov
• A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma#1453401ClinicalTrials.gov
• First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors#640545ClinicalTrials.gov
• A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.#903825ClinicalTrials.gov
• Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma#1350000ClinicalTrials.gov
• Rational Use of Herbal Products in Pediatric Patients Treated With Anticancer Drugs in the European Union#676877HAL (France)
• Study to See How Safe Curcumin is and How Well it Works When Used to Treat Mucositis in Patients Getting Chemotherapy#850670ClinicalTrials.gov
• A Study of CSCJC3456 in Patients With Advanced Malignant Tumors#908704ClinicalTrials.gov